Click here to Complete Eligibility Questionnaire Help Advance Research on CoQ10 Absorption in Healthy Adults Participate in a clinical research study evaluating how coenzymeQ10 (coQ10) is absorbed in the body. What is this Study about Coenzyme Q10 (CoQ10) is a naturally occurring compound involved in cellular energy production and antioxidant...
The U.S. Food and Drug Administration’s Bioresearch Monitoring (BIMO) program has entered a new phase of enforcement maturity. Once viewed primarily as a pharmaceutical oversight mechanism, BIMO has expanded into a robust compliance program that now actively scrutinizes clinical research in the food and dietary supplement sectors. Sponsors can no...
London, Ontario, Canada, 06 January, 2026 – KGK Science Inc., a leading full-service premium contract research organization (CRO) and regulatory consulting firm, today announced the publication of a randomized, triple-blind, placebo-controlled clinical trial conducted in collaboration with Unigen, Inc. The study has been published in the peer-reviewed journal Food Science...
Clinical research for nutraceuticals has evolved rapidly in recent years, especially with the rise of virtual clinical trials. These decentralized models bring clear advantages such as faster recruitment, larger sample sizes, and lower costs, but also new challenges, including limits on objective data collection and increased participant dropout risk. At...
London, Ontario, Canada, 23 October, 2025 – Cata-Kor, a U.S.-based nutraceutical company, today announced that it has entered into a research services agreement with KGK Science Inc., a leading North American contract research organization (CRO). Under this agreement, KGK will conduct a human clinical trial evaluating NAD+ Advanced, Cata-Kor’s high-dose NAD+...
London, Ontario, Canada, 03 October, 2025 – KGK Science Inc., a leading North American contract research organization and regulatory consulting firm, is proud to announce the successful approval of a Class III Product License Application (PLA) for Qlarity™, a unique product developed by Lucid Psycheceuticals. This approval grants Qlarity™ its...
sign up now to be added to our waiting list.
KGK Science has been delivering top-notch clinical research trials and expert regulatory support for the nutraceutical, cannabis, hemp, and psychedelic industries for over 27 years, aiding companies in bringing their products to global markets with custom trials and claim substantiation strategies.
Monday - Saturday 7:00 AM - 3:00 PM
